Drug intelligence / Profile preview

Fertivista Ultra

Development stage: Unknown
Lead developer: Gynavista
Modality: Small Molecules
Administration: Oral

Overview

Fertivista Ultra is a multi-ingredient dietary supplement developed by Gynavista for the management of male infertility. It is a finished pharmaceutical formulation presented as a softgel capsule. The product contains a blend of antioxidants, amino acids, and essential fatty acids, including Omega-3 fatty acids (EPA and DHA), Coenzyme Q10, Lycopene, Selenium, Wheat Germ oil, L-Arginine, L-Carnitine, and Zinc. These ingredients are intended to improve sperm quality, count, and motility by reducing oxidative stress, enhancing mitochondrial energy production, and supporting healthy spermatogenesis. It is commercially available in India as part of Gynavista's male infertility portfolio.

Brand names: Fertivista Ultra
Other names: Fertivista

Beyond the preview

Go deeper on Fertivista Ultra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fertivista Ultra.

Explore the full profile